Biopharmaceuticals
When developing the next generation therapeutics or vaccines, reliability and speed are in the heart of your success. Artel is helping biopharmaceutical labs get ahead and stay ahead.
Biopharmaceuticals
When developing the next generation therapeutics or vaccines, reliability and speed are in the heart of your success. Artel is helping biopharmaceutical labs get ahead and stay ahead.
Reduce your time-to-market by minimizing downtime
Shortening time to market is not only critical to meet patients’ needs, but it is also essential to stay ahead of competitors. Automating and taking control of your assay workflows can make the process more efficient. With Artel MVS and PCS, you can check your automated liquid instruments as often as needed, identify trends before failures happen, and avoid costly downtime.
Rosario Caltabiano
VP Business Development
We're here to help
Your workflow is only as strong as its weakest link, don’t let your instrument bring you down! If you have any questions about how Artel can help boost your productivity, please reach out!
Ensure high quality standards and compliance
Regulatory requirements in the biopharmaceutical industry are unique and demanding. The production of any therapeutics, vaccines or other drugs needs to comply with FDA 21 CFR, including GLP, GMP and other ISO standards. These regulations help provide confidence in the quality, safety and efficacy on the market. When it comes to your automated liquid handlers, pipettes, and personnel, Artel can support your efforts with training and services, including the first and only ISO 17025 accredited calibration service for automated liquid handlers.
Standardize your methods across instruments, people and locations
Whether you work at a small start-up, or a multi-site pharmaceutical company, the creation of harmonized protocols and operating standards is necessary to ensure reproducible results every time, no matter the instrument, location or the operator. With Artel, you can reduce variability from lot-to-lot, lab-to-lab and site-to-site across a global organization